REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 13 filers reported holding REGENERON PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329,184 | -87.6% | 400 | -89.2% | 0.00% | -90.0% |
Q2 2023 | $2,659,317 | +709.1% | 3,700 | +825.0% | 0.04% | +471.4% |
Q1 2023 | $328,668 | -8.9% | 400 | -20.0% | 0.01% | -12.5% |
Q4 2022 | $360,745 | -83.1% | 500 | -83.9% | 0.01% | -79.5% |
Q3 2022 | $2,136,000 | +22.3% | 3,100 | +24.0% | 0.04% | -36.1% |
Q1 2022 | $1,746,000 | +2.4% | 2,500 | -7.4% | 0.06% | +24.5% |
Q4 2021 | $1,705,000 | +156.0% | 2,700 | +145.5% | 0.05% | +133.3% |
Q3 2021 | $666,000 | -63.9% | 1,100 | -66.7% | 0.02% | -71.6% |
Q2 2021 | $1,843,000 | +224.5% | 3,300 | +175.0% | 0.07% | +196.0% |
Q1 2021 | $568,000 | -33.3% | 1,200 | -20.0% | 0.02% | -64.3% |
Q3 2020 | $851,000 | -9.0% | 1,500 | 0.0% | 0.07% | +9.4% |
Q2 2020 | $935,000 | – | 1,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IMC-Chicago, LLC | 73,100 | $35,315,000 | 0.04% |
GROUP ONE TRADING, L.P. | 46,700 | $22,561,000 | 0.04% |
SIMPLEX TRADING, LLC | 365 | $17,633,000 | 0.02% |
SG Americas Securities, LLC | 19,200 | $2,212,000 | 0.01% |
JPMORGAN CHASE & CO | 22,500 | $10,870,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |